Oxford Asset Management’s Assembly Biosciences ASMB Stock Holding History

Oxford Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,565	Closed	-$1.37M	–	299
2019 Q4	$1.37M	Sell	5,565 -10,417	-65%	-$1.92M	0.04%	653
2019 Q3	$1.89M	Sell	15,982 -1,479	-8%	-$224K	0.05%	583
2019 Q2	$2.83M	Buy	+17,461	New	+$3.32M	0.06%	478
2018 Q3	–	Sell	-1,585	Closed	-$755K	–	1681
2018 Q2	$755K	Sell	1,585 -1,732	-52%	-$916K	0.01%	1172
2018 Q1	$1.96M	Sell	3,317 -2,250	-40%	-$1.4M	0.04%	593
2017 Q4	$3M	Buy	5,567 +48	+0.9%	+$21.7K	0.06%	379
2017 Q3	$2.22M	Buy	5,519 +1,160	+27%	+$355K	0.04%	574
2017 Q2	$1.08M	Buy	+4,359	New	+$1.23M	0.02%	864

Other funds holding ASMB

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Oxford Asset Management's ASMB Position: Q1 2020 in Review

Oxford Asset Management sold out of Assembly Biosciences (ASMB) in Q1 2020, closing a stake of 5,565 shares — an estimated $1.37M sold.

Oxford Asset Management first reported a position in ASMB in Q2 2017 and held it in 8 quarters. The position peaked at $3M in Q4 2017. 98 funds tracked by Wall St. Rank hold ASMB as of Q1 2020.

Oxford Asset Management reported no remaining Assembly Biosciences position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 5,565 Assembly Biosciences shares in Q1 2020, an estimated $1.37M.
Oxford Asset Management first reported a position in Assembly Biosciences in Q2 2017 and held it in 8 quarters.
Oxford Asset Management's Assembly Biosciences position peaked at $3M in Q4 2017.
98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.